We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biological "Atlas" Reveals Immune Cell's Dual Personality

News   Mar 31, 2020 | Original story from St. Jude Children’s Research Hospital.

 
Biological "Atlas" Reveals Immune Cell's Dual Personality

Credit: Pixabay.

 
 
Advertisement
 

RELATED ARTICLES

Drug May Reduce Tumor Volume in Neurofibromatosis

News

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

READ MORE

Drug Combo for Rare Form of Cancer Shows Promise in Cell-Based Study

News

A rare form of lymphoma called Waldenström macroglobulinemia (WM), currently has no known cure and only one FDA-approved treatment. Researchers have now targeted specific cell proteins that control DNA information using inhibitors, that were effective in reducing the growth of the cancer cells. When combined with a third drug the combination was even more successful at killing the WM cancer cells.

READ MORE

Food Allergies Triggered by Our Overactive Quality Control System

News

Immunobiologists propose an expanded explanation for the rise of food allergies — the exaggerated activation of our complex food quality control system designed to protect us against eating harmful foods. Unnatural substances, including processed food and chemicals like dishwashing detergent and the absence of natural microbial exposure, play a role in disrupting this system, they argue.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE